Gordon M-M., Porter DR, Capell HADoes sulfasalazine cause drug induced lupus erythematosus? No effect evident in a prospective randomized trial of 200 rheumatoid patients treated with sulfasalazine or auranofin over five years. Ann Rheum Dis1999; 58: 288—290.
2.
Alarcon-Segovia D., Herslsovic T., Dearing WH, Bartholomew L., Cain J., Shorter R.Lupus erythematosus cell phenomenon in patients with chronic ulcerative colitis. Gut1965; 6: 39—47.
Elkayam O., Levarovosky D., Brautbar C. et al. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med1998; 105: 484—487.
5.
Lawson TM, Amos N., Bulgen D., William BDMinocycline induced lupus:Clinical features and response to rechallenge . Rheumatology2001; 40: 329—335.
6.
Hochberg MD, Kaslow RARisk factors for the development of systemic lupus erythematosus: A case-control study (abstract). Clin Res1983; 31: 732A.
7.
Freni-Titulaew Lwj, Kelley DB, Grow AG, McKinley TW, Arnett FC, Hochberg MCConnective tissue disease in southeastern Georgia: A case control study of etiologic factors . Am J Epidemiol1989; 130: 404—409.
8.
Petri M., Allbritton J.Hair product use in systemic lupus erythematosus — a case controlled study. Arthritis Rheum2002; 35: 625—629.
9.
Kilburn KH, Warshaw RHPrevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res1992; 57: 1—9.
10.
Walsh BT, Reed M., Emerson J., Gall EP, Clark L.A large cluster of systemic lupus erythematosus individuals in a Mexican-American border town in Arizona (abstract). Arthritis Rheum1993; 36: S145, B22.
11.
Kardestuncer T., Frumkin H.Systemic lupus erythematosus in relation to environmental pollution: An investigation in an African-American community in north Georgia. Arch Environ Health1997 ; 52: 85—90.
12.
Mohan AK, Edwards ET, Cote TR et al. Drug induced systemic lupus and anti-TNFalpha blockers. Lancet2002; 360: 646.
13.
Markham A., Lamb HMInfliximab: A review of its use in the management of rheumatoid arthritis . Drugs2000; 59: 1341—1359.
14.
Cush JJBiological drug use: US perspectives on indications and monitoring . Ann Rhuem Dis2005; 64: iv18—iv23.